COMMERCIALIZATION OF A NOVEL THERAPEUTIC FOR ALZHEIMER'S DISEASE

Project Number
2R42AG044187-02A1
Agency/Funding Organization
NIA
Funding Year
2017
Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
MARK
Principal Investigator Last Name
LOVELL
Awardee Organization
Awardee State
Contact PI Country
Project Detail
FY Overall Cost
$508,624
Funding Organization
Agency/Funding Organization
Funding Organization Country
Program Official